700 Industrial Park Drive
Alabaster, AL 35007
1-800-227-0651 or 205-663-2494
Fax 1-800-229-1004 or 205-663-0756

OrdersTechnical QuestionsGeneral Information
the phospholipid people
Synthetic Products
Lysophosphatidic Acid
Purity > 99%

  • LPA
  • Non-hydrolyzable Lyso PA
  • Cyclic Lyso PA
  • Non-hydrolyzable Cyclic Lyso PA
  • Other Lyso PA Derivatives

  • 1-Acyl-2-Hydroxy-sn-Glycero-3-Phosphate (Sodium Salt)
    857120
    1-tetradecanoyl-sn-glycero-3-phosphate (sodium salt)

    Chain
    Acyl Group
    M.W.
    Catalog Number
    6:0
    Hexanoyl
    287.25
    857119
    14:0
    Myristoyl
    404.42
    857120
    16:0
    Palmitoyl
    432.47
    857123
    17:0
    Heptadecanoyl
    432.47 
    857127
    Product Data
    18:0
    Stearoyl
    460.52
    857128
    18:1
    Oleoyl
    458.51
    857130
    20:4
    Arachidonoyl
    475.56
    857125
    Product Data
    Specify Chloroform or Powder
    Solubility /
    Solution Stability:
    Organic Solvents: Product is soluble in chloroform at all concentrations.
    Saturated analogs are more difficult to solubilize in organic solvents.
    Solubility of saturated analogs in chloroform is enhanced by adding small
    amounts of alcohol and water (to obtain a concentration of 10mg/ml saturated
    LPA in chloroform add 1.2% methanol and 0.6% water relative to chloroform
    volume)
    Biologically
    Compatible
    Solvents:
    Solubility in biologically compatible
    solvents such as dimethylsulfoxide (DMSO) or ethanol is limited. Product is
    completely soluble in ethanol:water (1:1, v/v), although heating and
    sonication may be necessary to disperse. Product is only partially soluble
    at higher ethanol content. Solubility in water (buffer) is limited to
    concentrations below the CMC of the molecule. In order to obtain maximum
    interaction with biological systems at concentrations above the CMC it is
    necessary to reduce the particle size of the micelle by sonication or
    absorption of the LPA to fatty acid serum albumin (BSA). LPA's bound to fatty acid free
    albumin will appear as clear solutions. Solution has been achieved in
    phosphate buffered saline (PBS), pH 7.2, at up to 0.3 mM (0.14 mg per ml) in
    the presence of 0.1% (w/v) bovine serum albumin (essentially fatty acid
    free).

    Note: Absorption of dilute stock solutions to plastic and glass can be a
    serious source of variation. Approximately 75% of a 5uM stock solution was found to stick tightly to the
    wall of an Eppendorf vial within 30 minutes.
    Storage: LPA should be stable in organic or aqueous solution at neutral
    conditions. Freezer storage (-20°C) is recommended for organic solutions
    (including ethanol:water, 1:1), while aqueous preparations (stable for 24-48
    hours) should be stored refrigerated (4°C). Partial acyl migration from the
    gamma (1) position to the beta (2) position may be possible under certain
    non-neutral conditions, such as those stimulating the formation of an
    equilibrium mixture of 1,2 and 1,3-diglycerides in acidic or basic solution.
    Oxidation of the fatty acid double bond may occur if submitted to oxidizing
    conditions. Maintaining the product under an inert atmosphere (nitrogen or
    argon) may be appropriate for some applications.
    Biological
    responses to LPA
    • Cell Proliferation
    • Inhibition of differentiation
      (neuroblastoma cells, myoblasts)
    • Platelet aggregation
    • Smooth muscle contraction
    • Neurotransmitter release
    • Stress fibre formation/cell rounding/neurite retraction
    • Cell-surface-fibronectin binding
    • Tumor cell invasion
    • Chemotaxis (dictyostelium amoebae)
    • Cl--mediated membrane depolarization (fibroblasts)
    • Inhibition of connexin 43 based cell-cell communication
    • Increased tight junction permeability
      (brain endothelial cells)
    Note: The bioactivity of LPA appears to require long (i.e., C16 to C18) acyl carbon chains of the type usually found associated with membrane lipids although optimum requirements for a single type of acyl carbon chain are not universal. The bioactivity decreases with shorter chain length. In serum, oleoyl and palmitoyl fatty acid containing LPA are the predominant species.
    Reference:
    Moolenaar, Wouter H.; Kranenburg, Onno; Postma, Friso R.; Zondag, Gerben C.M.: (1997), "Lysophosphatidic acid: G-protein signaling and cellular responses." Curr. Opin. Cell Biol. 9:168-173

    Non-hydrolyzable Lyso PA
    857228
    1-octadecyl-sn-glycero-3-phosphate (ammonium salt)

    Chain
    Acyl Group
    M.W.
    Catalog Number
    C16
    Hexadecyl
    413.54
    857223
    C18
    Octadecyl
    441.59
    857228
    C18:1
    Octadecenyl
    439.57
    857230

    Cyclic Lyso PA
    857328
    1-(9Z-octadecenoyl)-sn-glycero-2,3-cyclic-phosphate (ammonium salt)

    Chain
    Acyl Group
    M.W.
    Catalog Number
    16:0
    Palmitoyl
    410.51
    857323
    18:1
    Oleoyl
    436.55
    857328

    Non-hydrolyzable Cyclic Lyso PA
    857231
    1-(9Z-octadecenyl)-sn-glycero-2,3-cyclic-phosphate (ammonium salt)

    Chain
    Acyl Group
    M.W.
    Catalog Number
    C16
    Hexadecyl
    395.52
    857225
    C18:1
    Octadecenyl
    421.56
    857231

    Other Lyso PA Derivatives
    Chain
    M.W.
    Catalog Number
    12:0
    Biotinyl Lyso PA
    612.71
    860566
    14:0
    14:0 BMP (S,R)
    683.90
    857131
    18:1
    18:1 LBPA (S,R)
    792.09
    857133
    14:0
    14:0 Hemi BMP (S,R)
    894.26
    857132
    18:1
    18:1 Hemi BMP(S,R)
    1,056.54
    857134
    Product Data

    © Avanti Polar Lipids, Inc. All rights reserved.
    Terms of Use | Privacy Policy | Comments